5/21/2023 0 Comments Corona virus updateChildren 6 months through 5 years of age who are unvaccinated may receive a two-dose series of the Moderna bivalent vaccine (6 months through 5 years of age) OR a three-dose series of the Pfizer-BioNTech bivalent vaccine (6 months through 4 years of age).Most unvaccinated individuals may receive a single dose of a bivalent vaccine, rather than multiple doses of the original monovalent mRNA vaccines.However, for immunocompromised individuals 6 months through 4 years of age, eligibility for additional doses will depend on the vaccine previously received. Most individuals with certain kinds of immunocompromise who have received a bivalent COVID-19 vaccine may receive a single additional dose of a bivalent COVID-19 vaccine at least 2 months following a dose of a bivalent COVID-19 vaccine, and additional doses may be administered at the discretion of, and at intervals determined by, their healthcare provider.Individuals 65 years of age and older who have received a single dose of a bivalent vaccine may receive one additional dose at least four months following their initial bivalent dose.The FDA intends to make decisions about future vaccination after receiving recommendations on the fall strain composition at an FDA advisory committee in June. Most individuals who have already received a single dose of the bivalent vaccine are not currently eligible for another dose.Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of a bivalent vaccine may receive a single dose of a bivalent vaccine.The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. Thank you for your understanding on this matter, and we apologize for any inconvenience.Today, the U.S. If you have Medicare Advantage or a secondary payer, we recommend that you contact your insurer to confirm video visit coverage with these types of care providers. We don’t anticipate Medicare coverage issues for video visits with any other type of care provider. Please contact patient financial clearance at 73 if you would like a cost estimate. Note: Medicare patients have the option to pay for the services that insurance won’t cover. Only in-person visits with the above listed U-M Health providers will be covered by Medicare. In particular, Medicare will no longer cover video visits for U-M Health appointments with the following types of providers: Video visits with certain health care providers may no longer be covered by some health insurance plans. The Public Health Emergency that has been in place during the COVID-19 pandemic is ending on May 11, 2023. Some types of video visits may no longer be covered by Medicare. Medicare Coverage for Some Video Visits Ending
0 Comments
Leave a Reply. |